June 3, 2020
People living with Parkinson’s disease will soon have a new treatment option. The FDA has now approved a medication that…
May 22, 2020
New efforts to rein in Medicare costs could delay treatment for people who need botulinum toxins for migraine or movement disorders.
May 14, 2020
As the COVID-19 pandemic approaches its fourth month in the U.S., health care providers are growing weary.
May 7, 2020
Prior authorization was once a commonsense safeguard. But that is no longer the case.
April 27, 2020
A newly FDA-approved medication reflects how ongoing research continues to improve the treatment of Parkinson’s disease.
April 14, 2020
Neurologist and AfPA chairman David Charles, MD, discusses COVID-19 and telemedicine in this Alliance for Patient Access one-pager.
April 6, 2020
Neurologist Robert Fekete, MD, discusses COVID-19 and insurance prior authorization in this Alliance for Patient Access one-pager.
April 2, 2020
Reading the paper or watching the news can be stressful for anyone these days. But those with chronic medical or mental health conditions in particular may run the risk of becoming anxious or depressed.
March 18, 2020
The number of people with Parkinson’s disease doubled from 1990 to 2015 – and is expected to double again over the next 20 years. The disease’s growing prevalence underscores why increased awareness and research for brain illness remain critical.
February 17, 2020
The Federal Communications Commission’s proposal to create a three-digit suicide hotline is drawing praise from the patient advocacy community.
